The Wafer Level Chip Scale Packaging (WLCSP) Forum today announced it will participate in the 2nd Electronic System-Integration Technology Conference (ESTC) in Greenwich, London, UK, from September 1 through 4, 2008.
In work that could lead to new ways of detecting and treating malaria, MIT researchers have used two advanced microscopy techniques to show in unprecedented detail how the malaria parasite attacks red blood cells.
Researchers have developed a new type of property-changing polymer: It is water-repellent at 37 degrees C, which makes it an ideal culture substrate for biological cells. At room temperature it attracts water, allowing the cells to be detached easily from the substrate.
IMEC, Europe's leading independent nanoelectronics research institute and Plextronics, Inc., an international technology company specializing in printed solar, lighting and other organic electronics, signed an agreement to collaborate on state-of-the-art materials and inks for organic solar cells.
Am 27. September 2008 findet in Muenchen der Austausch von interessierten Buergerinnen und Buergern mit Experten statt. Organisiert wird die BMBF-Veranstaltung von Zukuenftige Technologien Consulting der VDI Technologiezentrum in Kooperation mit dem Deutschen Museum und der Muenchner Projektgruppe fuer Sozialforschung.
The interdisciplinary group of researchers applied emerging nanotechnology techniques to traditional cancer research to come up with a highly effective method for the preferential killing of cancer cells while leaving ordinary cells healthy.
Robert M. Dunn, most recently the director of the Integrated Engineering and Business Practices Program in the University of Notre Dame?s College of Engineering, has been named the managing director of the Center for Nano Science and Technology (NDnano) and the recently established Midwest Institute of Nanoelectronics Discovery (MIND).
A team of scientists has produced the image of an object at the highest resolution ever achieved with X-ray light. A 100-nanometre gold particle fixed on a substrate was reconstructed with 5 nanometre resolution.
By increasing the amount of an anticancer agent that gets to tumor cells, as opposed to healthy cells, researchers hope to minimize the potential side effects of therapy while maximizing therapeutic response. This approach has been taken one step farther by targeting the specific location inside a tumor cell, where the drug ceramide exerts its cell-killing activity.